OOIR: Observatory of International Research

Papers

(The H4-Index of Current Medicinal Chemistry is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Meet the Editorial Board Member	223
Artificial Intelligence: the “Trait D’Union” in Different Analysis Approaches of Autism Spectrum Disorder Studies	141
Conformational and Structural Characterization of Carbohydrates and their Interactions Studied by NMR	85
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties	79
Harnessing Phage Display for the Discovery of Peptide-Based Drugs and Monoclonal Antibodies	74
Corrigendum to: Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches	70
Interfering with the Reactive Cysteine Proteome in COVID-19	58
Meet the Editorial Board Member	58
Preface	53
Application of Machine Learning Techniques for Drug Discovery	52
Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy	51
Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR	49
Paneth Cells: Recent Updates on Elucidating Therapeutic Implications in Gastroenterological Disease Management	49
Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms	49
Intermittent Fasting and Fasting-mimicking Diet: Promising Strategies in Cancer Management	48
Challenges of Natural Anticancer and Anti-inflammatory Agents	48
Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers	43
The Pivotal Role of Transient Receptor Potential Channels in Oral Physiology	41
Statins, Allies against Antibiotic Resistance?	40
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation	40
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review	40
Ferroptosis Inducers for Prostate Cancer Therapy	39
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment	39
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus	38
Clinical Application and Synthesis Methods of Deuterated Drugs	38

Intimal Macrovascular Pericytes: Their Role in Vascular Biology and Atherogenesis	38
Resveratrol and Prostate Cancer: The Power of Phytochemicals	38
Role of Flavonoids in Management of Various Biological Targets in Alzheimer’s Disease: Evidence from Preclinical to Clinical Studies	37
Bacillus sp. Bacteriocins: Natural Weapons against Bacterial Enemies	37
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer	37
Long Non-coding RNA SNHG16 Facilitates Esophageal Cancer Cell Proliferation and Self-renewal through the microRNA-802/PTCH1 Axis	37
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery	37
Integrating Transcriptomic Data and Mendelian Randomization Analyses Reveals Potentially Novel Sepsis-related Targets	36
Mitochondrial DNA Mutations in Colorectal Cancer Stem Cells: Implications for Tumor Dynamics and Therapeutic Strategies	35
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2	34
Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors	34
Role of Ferroptosis in ALD: Focusing on Hepcidin and Besides Hepcidin	34
MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma	34
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile?	34
Construction and Biological Evaluation of Different Nanoshell Thickness Ni@SiO2 Nanotubes as Good Protein Separation Carriers for Bovine Hemoglobin	34